News and views

In a claim directed to a product for use in a medical treatment, the therapeutic effect is considered a functional, technical feature of the claim.

The Enlarged Board of Appeal (EBA) issued its much-awaited decision on case G1/24 yesterday (18 June 2025).

In a fascinating development of post-G 2/21 case law, decisions T0314/20 and T1525/19 reach opposite conclusions on near-identical subject-matter when considering whether post-published data can be used to support a technical effect. 

We are pleased to announce that Elkington + Fife will be sponsoring the IAM Live: AI and Emerging Tech IP Summit, which takes place on 26 February 2025 at The Westin London City, UK.